Quant Quantamental Fund Direct - Growth
Quant Quantamental Fund Direct - Growth: Mutual Fund Overview
Quant Quantamental Fund Direct - Growth is an Thematic-Quant mutual fund with over 4.86 years of performance history. The scheme manages an AUM of ₹1563.48 Cr and has a NAV of ₹23.7318. It is rated 'Not Rated' stars by analysts. Investors can begin a SIP with as little as ₹1000.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 11.64%.
Equity, Thematic-Quant, Principal at very high risk
1 Year Return 11.64% at 12 Mar 2026 07:55 PM
Fund Details
NAV 23.7318
Sub-Type Thematic-Quant
Rating Not Rated
Min. SIP Amount ₹1000.0
Fund Age(Year) 4.86
Fund Size(in Crores) 1563.48
Fund Performance
1 Month -5.19%
3 Month -5.76%
6 Month -0.2%
1 Year 11.64%
3 Year 19.43%
5 Year 0.0%
Know This Fund
As on 12 Mar 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (99.68%) Market Cap Large Cap 39.33 Mid Cap 27.12 Small Cap 33.23 Top Sectors Healthcare 99.68 Top Holding Illumina Inc. (USA) 0.14 Ajanta Pharma 0.88 Max Healthcare Institute 5.73 Eli Lilly 6.01 Laurus Labs 2.55 Biocon 1.41 Syngene International 0.52 Danaher Corporation 0.95 Glenmark Pharmaceuticals 2.24 Merck & Co Inc (US) 2.2 Vertex Pharmaceuticals Inc. (USA) 0.9 Glaxosmithkline Pharma 0.73 Gilead Sciences Inc. (USA) 1.31 Piramal Pharma 0.63 Aster DM Healthcare 1.03 Dr. Reddy's Laboratories 4.71 AbbVie Inc 2.91 Sun Pharmaceutical Industries 11.25 Iqvia Holdings 0.21 Agilent Technologies Inc 0.24 Apollo Hospitals Enterprise 5.69 Novo Nordisk A/S - ADR 0.86 Becton Dickinson And Co 0.36 Ipca Laboratories 1.44 Zydus Lifesciences 1.25 Novartis AG 2.28 Global Health 0.62 Intuitive Surgical Inc. (USA) 1.27 Cipla 5.14 Stryker Corp 0.94 Lupin 3.9 Medtronic 0.89 Amgen Inc. (USA) 1.48 Thermo Fisher Scientific Inc 1.37 Aurobindo Pharma 2.15 Torrent Pharmaceuticals 3.46 Gland Pharma 0.91 Mankind Pharma 1.88 Alkem Laboratories 1.82 Regeneron Pharmaceuticals Inc 0.58 Divi's Laboratories 5.17 Fortis Healthcare 3.12 Abbott Laboratories 1.42 Johnson & Johnson 4.25 Narayana Hrudayalaya 0.88
Debt & Others (0.32%) Sector Allocation Cash 0 Net Receivables 0.17 CBLO 0.15 Debt Credit Ratings Debt Category Others 0.32
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 1.7% Ret 1Y 11.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 1.41% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 0.88%
Exit Load 1.0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Sandeep Tandon
Education Mr. Tandon has done MBA (Finance)
Experience Prior to joining Quant Mutual Fund, he has worked with ICICI Securities as Vice President, The Economic Times and IDBI AMC.
Vasav Sahgal
Education B.Com. and CFA
Experience Prior to joining ITI AMC, he has worked with Quant Mutual Fund, Eqestar capital as Equity Research Analyst.
Sanjeev Sharma
Education Mr. Sharma is a Commerce Graduate and PGDBA (Finance) from Symbiosis, Pune.
Experience He has total work experience of 17 years including 13 years of experience in the financial market. He specializes in identifying crucial inflexion points in securities.
Ankit A Pande
Education Mr. Pande has done CFA and MBA
Experience Prior to joining Quant Mutual Fund he has worked with Infosys Finacle. Began his career in equity research in 2011.
Sameer Kate
Education Bachelor of Computer Science, MBA from IME Pune.
Experience Prior to joining Quant Mutual Fund, he was working with Investec Capital and Kotak Securities,
Yug Tibrewal
Education B.M.S, CFA L1
Experience Yug is an investment professional with over 2 years of experience in dealing related activities
Varun Pattani
Education Mr. Pattani is an ACA
Experience Prior to joining Quant Mutual Fund, he has worked with boutique PMS firm.
Ayusha Kumbhat
Education CFA Level III, BSc (Hons) in Economics, MSc in Behavioural & Experimental Economics
Experience She is working with Quant Mutual fund as Research Analyst for the past 15 months, specializing in investment research.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 5
Date of Incorporation 2021-05-03
Total AUM 88795.88
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
